Early Pregnancy Loss

Publication Date: November 1, 2018
Last Updated: March 14, 2022

Recommendations

In patients for whom medical management of early pregnancy loss is indicated, initial treatment using 800 micrograms of vaginal misoprostol is recommended, with a repeat dose as needed. The addition of a dose of mifepristone (200 mg orally) 24 hours before misoprostol administration may significantly improve treatment efficacy and should be considered when mifepristone is available. (A)
574

The use of anticoagulants, aspirin, or both, has not been shown to reduce the risk of early pregnancy loss in women with thrombophilias except in women with antiphospholipid syndrome. (A)
574

Ultrasonography, if available, is the preferred modality to verify the presence of a viable intrauterine gestation. (B)
574

Surgical intervention is not required in asymptomatic women with a thickened endometrial stripe after treatment for early pregnancy loss. (B)
574

The routine use of sharp curettage along with suction curettage in the first trimester does not provide any additional benefit as long as the obstetrician– gynecologist or other gynecologic provider is confident that the uterus is empty. (B)
574

Accepted treatment options for early pregnancy loss include expectant management, medical treatment, or surgical evacuation. In women without medical complications or symptoms requiring urgent surgical evacuation, treatment plans can safely accommodate patient treatment preferences. (C)
574

The use of a single preoperative dose of doxycycline is recommended to prevent infection after surgical management of early pregnancy loss. (C)
574

Although the risk of alloimmunization is low, the consequences can be significant, and administration of Rh D immune globulin should be considered in cases of early pregnancy loss, especially those that are later in the first trimester. (C)
574

Because of the higher risk of alloimmunization, Rh D-negative women who have surgical management of early pregnancy loss should receive Rh D immune globulin prophylaxis. (C)
574

Recommendation Grading

Overview

Title

Early Pregnancy Loss

Authoring Organization

Publication Month/Year

November 1, 2018

Last Updated Month/Year

January 23, 2024

Document Type

Consensus

External Publication Status

Published

Country of Publication

US

Inclusion Criteria

Female, Adolescent, Adult

Health Care Settings

Ambulatory, Outpatient

Intended Users

Physician, nurse midwife, nurse, nurse practitioner, physician assistant

Scope

Counseling, Management

Diseases/Conditions (MeSH)

D011247 - Pregnancy, D011248 - Pregnancy Complications

Keywords

pregnancy loss, early pregnancy, first trimester